Song, Yan
Park, Paul M. C.
Wu, Lei
Ray, Arghya
Picaud, Sarah
Li, Deyao
Wimalasena, Virangika K.
Du, Ting
Filippakopoulos, Panagis
Anderson, Kenneth C.
Qi, Jun
Chauhan, Dharminder
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA207237, RO1CA050947, R01CA207237, RO1CA050947)
Article History
Received: 8 February 2019
Accepted: 25 March 2019
First Online: 8 April 2019
Compliance with ethical standards
:
: KCA is on Advisory board of Celgene, Millenium-Takeda, Gilead, Janssen, and Bristol Myers Squibb, and is a Scientific Founder of Oncopep and C4 Therapeutics. DC is consultant to Stemline Therapeutic, Inc., and Equity owner in C4 Therapeutics. All the remaining authors declare no conflict of interest.